_id
691847703c536f8df231783c
Ticker
ZNTL
Name
Zentalis Pharmaceuticals Llc
Exchange
NASDAQ
Address
10275 Science Center Dr., San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://zentalis.com
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Last Close
1.45
Volume
633255
Current Price
1.4
Change
-3.448275862068969
Last Updated
2025-12-05T14:19:12.894Z
Image
https://logo.clearbit.com/zentalis.com
Ipo Date
2020-04-03T00:00:00.000Z
Market Cap
101151088
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.979
Sentiment Sources
1
Rating
3.7
Target Price
5.3125
Strong Buy
3
Buy
1
Hold
6
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
33734000
Operating Income
-33734000
Interest Expense
-
Pretax Income
-26691000
Net Income
-26691000
Eps
-0.3699940392852687
Dividends Per Share
-
Shares Outstanding
72250779
Income Tax Expense
-
EBITDA
-26531000
Operating Margin
-
Total Other Income Expense Net
7043000
Cash
39072000
Short Term Investments
241625000
Receivables
-
Inventories
-
Total Current Assets
288302000
Property Plant Equipment
33115000
Total Assets
327250000
Payables
7031000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
74376000
Equity
252874000
Depreciation
160000
Change In Working Capital
-1170000
Cash From Operations
-26963000
Capital Expenditures
0
Cash From Investing
28321000
Cash From Financing
115000
Net Change In Cash
1473000
PE
-
PB
0.3993870465132833
ROE
-10.555059041261657
ROA
-8.156149732620321
FCF
-26963000
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
7
Quality Investing Score
3
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
33734000
Quarters > 0 > income Statement > operating Income
-33734000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-26691000
Quarters > 0 > income Statement > net Income
-26691000
Quarters > 0 > income Statement > eps
-0.3699940392852687
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
72139000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-26531000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
7043000
Quarters > 0 > balance Sheet > cash
39072000
Quarters > 0 > balance Sheet > short Term Investments
241625000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
288302000
Quarters > 0 > balance Sheet > property Plant Equipment
33115000
Quarters > 0 > balance Sheet > total Assets
327250000
Quarters > 0 > balance Sheet > payables
7031000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
74376000
Quarters > 0 > balance Sheet > equity
252874000
Quarters > 0 > cash Flow > net Income
-26691000
Quarters > 0 > cash Flow > depreciation
160000
Quarters > 0 > cash Flow > change In Working Capital
-1170000
Quarters > 0 > cash Flow > cash From Operations
-26963000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
28321000
Quarters > 0 > cash Flow > cash From Financing
115000
Quarters > 0 > cash Flow > net Change In Cash
1473000
Quarters > 0 > ratios > PE
-0.3699940392852687
Quarters > 0 > ratios > PB
0.3993870465132833
Quarters > 0 > ratios > ROE
-10.555059041261657
Quarters > 0 > ratios > ROA
-8.156149732620321
Quarters > 0 > ratios > FCF
-26963000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
160000
Quarters > 1 > income Statement > gross Profit
-160000
Quarters > 1 > income Statement > operating Expenses
36058000
Quarters > 1 > income Statement > operating Income
-36058000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-26874000
Quarters > 1 > income Statement > net Income
-26874000
Quarters > 1 > income Statement > eps
-0.373291476830759
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
71992000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-34746000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
9184000
Quarters > 1 > balance Sheet > cash
37599000
Quarters > 1 > balance Sheet > short Term Investments
265832000
Quarters > 1 > balance Sheet > receivables
2453000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
311596000
Quarters > 1 > balance Sheet > property Plant Equipment
34262000
Quarters > 1 > balance Sheet > total Assets
351707000
Quarters > 1 > balance Sheet > payables
3719000
Quarters > 1 > balance Sheet > short Term Debt
3627000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
77212000
Quarters > 1 > balance Sheet > equity
274495000
Quarters > 1 > cash Flow > net Income
-26874000
Quarters > 1 > cash Flow > depreciation
160000
Quarters > 1 > cash Flow > change In Working Capital
-8328000
Quarters > 1 > cash Flow > cash From Operations
-34708000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
30378000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-4330000
Quarters > 1 > ratios > PE
-0.373291476830759
Quarters > 1 > ratios > PB
0.36717900143900617
Quarters > 1 > ratios > ROE
-9.790342264886426
Quarters > 1 > ratios > ROA
-7.641019371237991
Quarters > 1 > ratios > FCF
-34708000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
262000
Quarters > 2 > income Statement > gross Profit
-262000
Quarters > 2 > income Statement > operating Expenses
45623000
Quarters > 2 > income Statement > operating Income
-45623000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-48279000
Quarters > 2 > income Statement > net Income
-48279000
Quarters > 2 > income Statement > eps
-0.673553949607969
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
71678000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-37565000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-2656000
Quarters > 2 > balance Sheet > cash
41929000
Quarters > 2 > balance Sheet > short Term Investments
290524000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
342882000
Quarters > 2 > balance Sheet > property Plant Equipment
35172000
Quarters > 2 > balance Sheet > total Assets
384021000
Quarters > 2 > balance Sheet > payables
7769000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
88639000
Quarters > 2 > balance Sheet > equity
295382000
Quarters > 2 > cash Flow > net Income
-48279000
Quarters > 2 > cash Flow > depreciation
262000
Quarters > 2 > cash Flow > change In Working Capital
1754000
Quarters > 2 > cash Flow > cash From Operations
-32636000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
40475000
Quarters > 2 > cash Flow > cash From Financing
189000
Quarters > 2 > cash Flow > net Change In Cash
8028000
Quarters > 2 > ratios > PE
-0.673553949607969
Quarters > 2 > ratios > PB
0.3397268621649254
Quarters > 2 > ratios > ROE
-16.344597842793398
Quarters > 2 > ratios > ROA
-12.5719687204606
Quarters > 2 > ratios > FCF
-32636000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
26865000
Quarters > 3 > income Statement > cost Of Revenue
317000
Quarters > 3 > income Statement > gross Profit
26865000
Quarters > 3 > income Statement > operating Expenses
76714000
Quarters > 3 > income Statement > operating Income
-49849000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-47677000
Quarters > 3 > income Statement > net Income
-47472000
Quarters > 3 > income Statement > eps
-0.6663899213184863
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
71237572
Quarters > 3 > income Statement > income Tax Expense
-205000
Quarters > 3 > income Statement > EBITDA
-45796000
Quarters > 3 > income Statement > operating Margin
-185.5536943979155
Quarters > 3 > income Statement > total Other Income Expense Net
2172000
Quarters > 3 > balance Sheet > cash
33901000
Quarters > 3 > balance Sheet > short Term Investments
337183000
Quarters > 3 > balance Sheet > receivables
5000000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
386066000
Quarters > 3 > balance Sheet > property Plant Equipment
37227000
Quarters > 3 > balance Sheet > total Assets
430337000
Quarters > 3 > balance Sheet > payables
7438000
Quarters > 3 > balance Sheet > short Term Debt
3072000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
93151000
Quarters > 3 > balance Sheet > equity
337186000
Quarters > 3 > cash Flow > net Income
-47472000
Quarters > 3 > cash Flow > depreciation
317000
Quarters > 3 > cash Flow > change In Working Capital
-7076000
Quarters > 3 > cash Flow > cash From Operations
-39702000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
32283000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-7419000
Quarters > 3 > ratios > PE
-0.6663899213184863
Quarters > 3 > ratios > PB
0.29577918656171964
Quarters > 3 > ratios > ROE
-14.0788763471793
Quarters > 3 > ratios > ROA
-11.031354496592204
Quarters > 3 > ratios > FCF
-39702000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.4778336125069793
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
67425000
Annuals > 0 > income Statement > cost Of Revenue
1289000
Annuals > 0 > income Statement > gross Profit
67425000
Annuals > 0 > income Statement > operating Expenses
258619000
Annuals > 0 > income Statement > operating Income
-191194000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-165690000
Annuals > 0 > income Statement > net Income
-165839000
Annuals > 0 > income Statement > eps
-2.3331316826111426
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
71080000
Annuals > 0 > income Statement > income Tax Expense
177000
Annuals > 0 > income Statement > EBITDA
-186169000
Annuals > 0 > income Statement > operating Margin
-283.56544308490913
Annuals > 0 > income Statement > total Other Income Expense Net
25504000
Annuals > 0 > balance Sheet > cash
33901000
Annuals > 0 > balance Sheet > short Term Investments
337183000
Annuals > 0 > balance Sheet > receivables
5000000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
386066000
Annuals > 0 > balance Sheet > property Plant Equipment
37227000
Annuals > 0 > balance Sheet > total Assets
430337000
Annuals > 0 > balance Sheet > payables
7438000
Annuals > 0 > balance Sheet > short Term Debt
3072000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
93151000
Annuals > 0 > balance Sheet > equity
337186000
Annuals > 0 > cash Flow > net Income
-165867000
Annuals > 0 > cash Flow > depreciation
1289000
Annuals > 0 > cash Flow > change In Working Capital
-16540000
Annuals > 0 > cash Flow > cash From Operations
-170860000
Annuals > 0 > cash Flow > capital Expenditures
221000
Annuals > 0 > cash Flow > cash From Investing
176561000
Annuals > 0 > cash Flow > cash From Financing
108000
Annuals > 0 > cash Flow > net Change In Cash
5809000
Annuals > 0 > ratios > PE
-2.3331316826111426
Annuals > 0 > ratios > PB
0.29512494587557014
Annuals > 0 > ratios > ROE
-49.18324011079938
Annuals > 0 > ratios > ROA
-38.53700704331721
Annuals > 0 > ratios > FCF
-171081000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-2.537352614015573
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1389000
Annuals > 1 > income Statement > gross Profit
-1389000
Annuals > 1 > income Statement > operating Expenses
299509000
Annuals > 1 > income Statement > operating Income
-299509000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-292906000
Annuals > 1 > income Statement > net Income
-292191000
Annuals > 1 > income Statement > eps
-4.467137549878457
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
65409000
Annuals > 1 > income Statement > income Tax Expense
-601000
Annuals > 1 > income Statement > EBITDA
-247599000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
6603000
Annuals > 1 > balance Sheet > cash
28038000
Annuals > 1 > balance Sheet > short Term Investments
454881000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
496718000
Annuals > 1 > balance Sheet > property Plant Equipment
41735000
Annuals > 1 > balance Sheet > total Assets
562027000
Annuals > 1 > balance Sheet > payables
14926000
Annuals > 1 > balance Sheet > short Term Debt
2623000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
124636000
Annuals > 1 > balance Sheet > equity
437284000
Annuals > 1 > cash Flow > net Income
-292191000
Annuals > 1 > cash Flow > depreciation
1389000
Annuals > 1 > cash Flow > change In Working Capital
5864000
Annuals > 1 > cash Flow > cash From Operations
-207822000
Annuals > 1 > cash Flow > capital Expenditures
583000
Annuals > 1 > cash Flow > cash From Investing
-44458000
Annuals > 1 > cash Flow > cash From Financing
237303000
Annuals > 1 > cash Flow > net Change In Cash
-14977000
Annuals > 1 > ratios > PE
-4.467137549878457
Annuals > 1 > ratios > PB
0.20941218978970189
Annuals > 1 > ratios > ROE
-66.81950402941796
Annuals > 1 > ratios > ROA
-51.98878345702253
Annuals > 1 > ratios > FCF
-208405000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1426000
Annuals > 2 > income Statement > gross Profit
-1426000
Annuals > 2 > income Statement > operating Expenses
227287000
Annuals > 2 > income Statement > operating Income
-227287000
Annuals > 2 > income Statement > interest Expense
2575000
Annuals > 2 > income Statement > pretax Income
-237582000
Annuals > 2 > income Statement > net Income
-236806000
Annuals > 2 > income Statement > eps
-4.4801256219611405
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
52857000
Annuals > 2 > income Statement > income Tax Expense
-469000
Annuals > 2 > income Statement > EBITDA
-225861000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-10295000
Annuals > 2 > balance Sheet > cash
43069000
Annuals > 2 > balance Sheet > short Term Investments
394302000
Annuals > 2 > balance Sheet > receivables
7041000
Annuals > 2 > balance Sheet > inventories
-7041000
Annuals > 2 > balance Sheet > total Current Assets
451933000
Annuals > 2 > balance Sheet > property Plant Equipment
50078000
Annuals > 2 > balance Sheet > total Assets
553457000
Annuals > 2 > balance Sheet > payables
11247000
Annuals > 2 > balance Sheet > short Term Debt
2162000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
119433000
Annuals > 2 > balance Sheet > equity
433803000
Annuals > 2 > cash Flow > net Income
-237113000
Annuals > 2 > cash Flow > depreciation
1426000
Annuals > 2 > cash Flow > change In Working Capital
13252000
Annuals > 2 > cash Flow > cash From Operations
-163751000
Annuals > 2 > cash Flow > capital Expenditures
2548000
Annuals > 2 > cash Flow > cash From Investing
-114180000
Annuals > 2 > cash Flow > cash From Financing
261043000
Annuals > 2 > cash Flow > net Change In Cash
-16888000
Annuals > 2 > ratios > PE
-4.4801256219611405
Annuals > 2 > ratios > PB
0.17058388254576384
Annuals > 2 > ratios > ROE
-54.588373063349025
Annuals > 2 > ratios > ROA
-42.78670248998567
Annuals > 2 > ratios > FCF
-166299000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
544000
Annuals > 3 > income Statement > gross Profit
-544000
Annuals > 3 > income Statement > operating Expenses
216542000
Annuals > 3 > income Statement > operating Income
-216542000
Annuals > 3 > income Statement > interest Expense
110047000
Annuals > 3 > income Statement > pretax Income
-166390000
Annuals > 3 > income Statement > net Income
-158725000
Annuals > 3 > income Statement > eps
-3.7182580584707647
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
42688000
Annuals > 3 > income Statement > income Tax Expense
-297000
Annuals > 3 > income Statement > EBITDA
-207198000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
50152000
Annuals > 3 > balance Sheet > cash
59957000
Annuals > 3 > balance Sheet > short Term Investments
280173000
Annuals > 3 > balance Sheet > receivables
2635000
Annuals > 3 > balance Sheet > inventories
-4439000
Annuals > 3 > balance Sheet > total Current Assets
350770000
Annuals > 3 > balance Sheet > property Plant Equipment
52839000
Annuals > 3 > balance Sheet > total Assets
472025000
Annuals > 3 > balance Sheet > payables
11590000
Annuals > 3 > balance Sheet > short Term Debt
1453000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
107543000
Annuals > 3 > balance Sheet > equity
363954000
Annuals > 3 > cash Flow > net Income
-166093000
Annuals > 3 > cash Flow > depreciation
544000
Annuals > 3 > cash Flow > change In Working Capital
16605000
Annuals > 3 > cash Flow > cash From Operations
-154093000
Annuals > 3 > cash Flow > capital Expenditures
6107000
Annuals > 3 > cash Flow > cash From Investing
-18115000
Annuals > 3 > cash Flow > cash From Financing
178521000
Annuals > 3 > cash Flow > net Change In Cash
6313000
Annuals > 3 > ratios > PE
-3.7182580584707647
Annuals > 3 > ratios > PB
0.16420536661226418
Annuals > 3 > ratios > ROE
-43.611280546442686
Annuals > 3 > ratios > ROA
-33.62639690694349
Annuals > 3 > ratios > FCF
-160200000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.3699940392852687
Valuation > metrics > PB
0.3993870465132833
Valuation > final Score
70
Valuation > verdict
60.1% Undervalued
Profitability > metrics > ROE
-10.555059041261657
Profitability > metrics > ROA
-9.258000291361142
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2941227646970428
Risk > metrics > Interest Coverage
-210.8375
Risk > final Score
-783
Risk > verdict
High
Liquidity > metrics > Current Ratio
41.00440904565496
Liquidity > metrics > Quick Ratio
41.00440904565496
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
42
Prev Risks > 1
43
Prev Risks > 2
-46
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:28:10.307Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-03
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.37
Earnings History > 0 > eps Estimate
-0.5278
Earnings History > 0 > eps Difference
0.1578
Earnings History > 0 > surprise Percent
29.8977
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.37
Earnings History > 1 > eps Estimate
-0.54
Earnings History > 1 > eps Difference
0.17
Earnings History > 1 > surprise Percent
31.4815
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.67
Earnings History > 2 > eps Estimate
-0.6069
Earnings History > 2 > eps Difference
-0.0631
Earnings History > 2 > surprise Percent
-10.3971
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.6138
Earnings History > 3 > eps Estimate
-0.6817
Earnings History > 3 > eps Difference
0.0679
Earnings History > 3 > surprise Percent
9.9604
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-04
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.56
Earnings History > 4 > eps Estimate
-0.8708
Earnings History > 4 > eps Difference
0.3108
Earnings History > 4 > surprise Percent
35.6913
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.24
Earnings History > 5 > eps Estimate
-0.84
Earnings History > 5 > eps Difference
-0.4
Earnings History > 5 > surprise Percent
-47.619
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.14
Earnings History > 6 > eps Estimate
-0.77
Earnings History > 6 > eps Difference
0.91
Earnings History > 6 > surprise Percent
118.1818
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.93
Earnings History > 7 > eps Estimate
-0.92
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-1.087
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-06
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.79
Earnings History > 8 > eps Estimate
-0.91
Earnings History > 8 > eps Difference
0.12
Earnings History > 8 > surprise Percent
13.1868
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-09
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.85
Earnings History > 9 > eps Estimate
-1.04
Earnings History > 9 > eps Difference
-0.81
Earnings History > 9 > surprise Percent
-77.8846
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.07
Earnings History > 10 > eps Estimate
-1.02
Earnings History > 10 > eps Difference
-0.05
Earnings History > 10 > surprise Percent
-4.902
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-01
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.92
Earnings History > 11 > eps Estimate
-1.06
Earnings History > 11 > eps Difference
0.14
Earnings History > 11 > surprise Percent
13.2075
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.96
Earnings History > 12 > eps Estimate
-1.17
Earnings History > 12 > eps Difference
0.21
Earnings History > 12 > surprise Percent
17.9487
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.34
Earnings History > 13 > eps Estimate
-1.19
Earnings History > 13 > eps Difference
-0.15
Earnings History > 13 > surprise Percent
-12.605
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.31
Earnings History > 14 > eps Estimate
-1.22
Earnings History > 14 > eps Difference
-0.09
Earnings History > 14 > surprise Percent
-7.377
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.11
Earnings History > 15 > eps Estimate
-1.49
Earnings History > 15 > eps Difference
0.38
Earnings History > 15 > surprise Percent
25.5034
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.25
Earnings History > 16 > eps Estimate
-1.31
Earnings History > 16 > eps Difference
0.06
Earnings History > 16 > surprise Percent
4.5802
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1.34
Earnings History > 17 > eps Estimate
-1.17
Earnings History > 17 > eps Difference
-0.17
Earnings History > 17 > surprise Percent
-14.5299
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-17
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.24
Earnings History > 18 > eps Estimate
-0.97
Earnings History > 18 > eps Difference
-0.27
Earnings History > 18 > surprise Percent
-27.8351
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.01
Earnings History > 19 > eps Estimate
-0.95
Earnings History > 19 > eps Difference
-0.06
Earnings History > 19 > surprise Percent
-6.3158
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.91
Earnings History > 20 > eps Estimate
-0.81
Earnings History > 20 > eps Difference
-0.1
Earnings History > 20 > surprise Percent
-12.3457
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-13
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.78
Earnings History > 21 > eps Estimate
-0.5
Earnings History > 21 > eps Difference
-0.28
Earnings History > 21 > surprise Percent
-56
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-15
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-2.88
Earnings History > 22 > eps Estimate
-0.7
Earnings History > 22 > eps Difference
-2.18
Earnings History > 22 > surprise Percent
-311.4286
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AZentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market Seeking Alpha
Read more →Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Recommendation of "Hold" from Brokerages MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$5.3125
Analyst Picks
Strong Buy
3
Buy
1
Hold
6
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 65.48% of the total shares of Zentalis Pharmaceuticals Llc
1.
Matrix Capital Management Company, LLC(19.3524%)
since
2025/06/30
2.
Millennium Management LLC(4.8198%)
since
2025/06/30
3.
Vanguard Group Inc(3.9989%)
since
2025/06/30
4.
Opaleye Management Inc(2.6676%)
since
2025/06/30
5.
BlackRock Inc(2.4146%)
since
2025/06/30
6.
Almitas Capital LLC(2.217%)
since
2025/06/30
7.
TANG CAPITAL MANAGEMENT LLC(2.1487%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.1424%)
since
2025/07/31
9.
Renaissance Technologies Corp(2.1204%)
since
2025/06/30
10.
Tybourne Capital Management (HK) Ltd(2.0491%)
since
2025/06/30
11.
Decheng Capital LLC(1.8345%)
since
2025/06/30
12.
Two Sigma Advisers, LLC(1.7688%)
since
2025/06/30
13.
D. E. Shaw & Co LP(1.6602%)
since
2025/06/30
14.
GSA Capital Partners LLP(1.5712%)
since
2025/06/30
15.
Morgan Stanley - Brokerage Accounts(1.5217%)
since
2025/06/30
16.
Two Sigma Investments LLC(1.5153%)
since
2025/06/30
17.
PRIMECAP Management Company(1.4246%)
since
2025/06/30
18.
Balyasny Asset Management LLC(1.3459%)
since
2025/06/30
19.
Pfizer Inc(1.3223%)
since
2025/06/30
20.
Goldman Sachs Group Inc(1.1947%)
since
2025/06/30
21.
Jacobs Levy Equity Management, Inc.(1.1888%)
since
2025/06/30
22.
PRIMECAP Odyssey Aggressive Growth(1.0278%)
since
2025/06/30
23.
Vanguard Institutional Extnd Mkt Idx Tr(0.8538%)
since
2025/07/31
24.
Fidelity Extended Market Index(0.4179%)
since
2025/07/31
25.
Vanguard US Opportunities Ins USD Acc(0.3703%)
since
2025/06/30
26.
Schwab US Small-Cap ETF™(0.3563%)
since
2025/08/30
27.
Vanguard Strategic Small-Cap Equity Inv(0.2902%)
since
2025/06/30
28.
Acadian Global Small-Cap Equity CIT Cl A(0.2316%)
since
2025/03/04
29.
Invesco RAFI US 1500 Small-Mid ETF(0.2112%)
since
2025/08/29
30.
Fidelity Enhanced Small Cap ETF(0.1979%)
since
2025/08/29
31.
iShares Micro-Cap ETF(0.1759%)
since
2025/08/31
32.
Vanguard Health Care ETF(0.1572%)
since
2025/07/31
33.
Extended Equity Market Fund K(0.1532%)
since
2025/06/30
34.
Fidelity Total Market Index(0.1392%)
since
2025/07/31
35.
Multi-Manager Small Cap Eq Strat Inst(0.1264%)
since
2025/07/31
36.
Fidelity Series Total Market Index(0.1113%)
since
2025/07/31
37.
Bridgeway Ultra-Small Company Market(0.1072%)
since
2025/06/30
38.
Spartan Extended Market Index Pool F(0.096%)
since
2025/07/31
39.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.089%)
since
2025/03/31
40.
NT Ext Equity Mkt Idx Fd - L(0.0874%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.37
EPS Estimate
-0.5278
EPS Difference
0.1578
Surprise Percent
29.8977%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.